Top 10 Deals of 2023: Breast Cancer Therapeutic Company is Acquired by Gilead
This week we discuss what the acquisition of XinThera means for the industry and consider similar pioneers in the women’s health space.
Top 10 Deals of 2023: Kindbody Announces $100 Million Raise
This week we reflect on the remarkable trajectory of Kindbody’s growth, applauding their substantial fundraising achievements, underscoring the positivity it brings to the women’s health sector.
Top 10 Deals of 2023: Pregnancy Care Company, Nuvo Group, merges with LAMF Global Ventures
This week we discuss what the merger of Nuvo Group and LAMF Global Ventures means for the industry and consider similar pioneers in the women’s health space.
Top 10 Deals of 2023: Thorne HealthTech Acquired for $680M by L. Catterton
This week we discuss what the acquisition of Thorne HealthTech means for the industry and consider similar pioneers in the women’s health space.
Evvy, an Amboy Street Portfolio Company, Raises a $14M SeriesA
Amboy Street Ventures announces its latest investment in Evvy, a company committed to restoring equity in healthcare by leveraging overlooked female biomarkers, starting with the vaginal microbiome.
Industry Insights: What CPG Conglomerates Look for in Acquisition Targets
This week, Ute M. Arndt, reveals what CPG conglomerates find valuable when considering an acquisition of a start-up.
Industry Insights: Three Predictions for the Future of Fertility by Author and Investor, Leslie Schrock
This week, Leslie Schrock, breaks down the future of fertility – what trends to look for and which markets to bet on.
Amboy Street Ventures Joins HerMD’s $18M Round
Amboy Street invests in HerMD which offers menopause and sexual health care through a hybrid delivery model with in-person and virtual services.
Industry Insights: Navigating the Payer Maze by Bayer Executive, Laura Clark-Kelly
This week Bayer Exec, Laura Clark-Kelly, speaks to the complex nature of obtaining insurance coverage for women’s health and sexual wellness companies.